We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.48%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.8B
AUM Growth
+$629M
Cap. Flow
-$312M
Cap. Flow %
-2.1%
Top 10 Hldgs %
24.14%
Holding
917
New
50
Increased
256
Reduced
457
Closed
57

Top Buys

Rank Stock Value
1
VERU icon
Veru
VERU
+$53M
2
MELI icon
Mercado Libre
MELI
+$43.2M
3
DAR icon
Darling Ingredients
DAR
+$41.7M
4
JNJ icon
Johnson & Johnson
JNJ
+$33.7M
5
MET icon
MetLife
MET
+$31.1M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$46.1M
2
NKE icon
Nike
NKE
+$36.6M
3
ITW icon
Illinois Tool Works
ITW
+$35.8M
4
AAPL icon
Apple
AAPL
+$31.9M
5
GILD icon
Gilead Sciences
GILD
+$29.8M

Sector Composition

Rank Sector Weight
1 Healthcare 33.32%
2 Technology 22.84%
3 Financials 10.04%
4 Consumer Discretionary 7.69%
5 Industrials 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANSS
76
DELISTED
Ansys
ANSS
$46.8M 0.32%
193,583
+20,629
+12% +$4.8M
CDNS icon
77
Cadence Design Systems
CDNS
$93.4B
$46M 0.31%
286,173
+87,821
+44% +$14M
MTZ icon
78
MasTec
MTZ
$26.6B
$45.7M 0.31%
535,704
+2,430
+0.5% +$199K
SBUX icon
79
Starbucks
SBUX
$118B
$45.5M 0.31%
458,408
-182,515
-28% -$17.2M
ISRG icon
80
Intuitive Surgical
ISRG
$128B
$45.2M 0.3%
170,170
-21,012
-11% -$5.12M
CRM icon
81
Salesforce
CRM
$142B
$43.9M 0.3%
330,982
-170,132
-34% -$24.8M
ED icon
82
Consolidated Edison
ED
$41.1B
$43.8M 0.3%
459,287
+224,278
+95% +$20.4M
CL icon
83
Colgate-Palmolive
CL
$73.6B
$43.7M 0.29%
554,380
+88,832
+19% +$6.66M
ADP icon
84
Automatic Data Processing
ADP
$102B
$43.2M 0.29%
180,800
-33,082
-15% -$8.12M
PNC icon
85
PNC Financial Services
PNC
$99.6B
$42.3M 0.29%
267,685
+19,770
+8% +$3.11M
AZN icon
86
AstraZeneca
AZN
$263B
$40.6M 0.27%
299,272
-5,742
-2% -$720K
ABBV icon
87
AbbVie
ABBV
$454B
$40.4M 0.27%
250,176
-69,902
-22% -$10.7M
VZ icon
88
Verizon
VZ
$198B
$39.4M 0.27%
999,275
-80,604
-7% -$3.04M
ACGL icon
89
Arch Capital
ACGL
$36.3B
$38.1M 0.26%
607,080
-184,394
-23% -$10.3M
ALL icon
90
Allstate
ALL
$67.3B
$37.9M 0.26%
279,523
+110,473
+65% +$14.4M
HALO icon
91
Halozyme
HALO
$9.66B
$37.1M 0.25%
652,302
-1,373
-0.2% -$70.3K
NEE icon
92
NextEra Energy
NEE
$185B
$37M 0.25%
442,508
+76,436
+21% +$6.17M
MDLZ icon
93
Mondelez International
MDLZ
$77.9B
$36.8M 0.25%
551,906
+308,257
+127% +$19.5M
BIO icon
94
Bio-Rad Laboratories Class A
BIO
$8.47B
$36.4M 0.25%
86,478
-9,157
-10% -$3.7M
TD icon
95
Toronto Dominion Bank
TD
$198B
$36.2M 0.24%
560,252
-62,533
-10% -$4.04M
EXEL icon
96
Exelixis
EXEL
$14B
$36M 0.24%
2,243,038
+172,085
+8% +$2.81M
SYK icon
97
Stryker
SYK
$129B
$35.7M 0.24%
146,181
+91,477
+167% +$20.8M
EL icon
98
Estee Lauder
EL
$30.1B
$35.3M 0.24%
142,368
-87,276
-38% -$19.5M
OTIS icon
99
Otis Worldwide
OTIS
$27.9B
$34.8M 0.23%
444,718
-91,822
-17% -$6.78M
BCYC
100
Bicycle Therapeutics
BCYC
$276M
$34.8M 0.23%
1,175,211
-57,043
-5% -$1.53M
2 3
4
5 6

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2022 Portfolio in Review

As of Q4 2022, Candriam SCA held 917 positions worth $14.8B, up 4.4% from $14.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA's Q4 2022 filing shows 50 new, 256 increased, 457 reduced and 57 closed positions. Its largest new stake was Sarepta Therapeutics: 95,144 shares worth $12.3M. The largest sale was PepsiCo, an estimated $46.1M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2022 buy was Sarepta Therapeutics: 95,144 shares worth $12.3M.
  • Candriam SCA added most to Veru in Q4 2022, an estimated $53M increase.
  • Candriam SCA's biggest Q4 2022 reduction was PepsiCo, cutting an estimated $46.1M.
  • Candriam SCA fully exited Global Blood Therapeutics, Inc. in Q4 2022, selling an estimated $24.6M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.8B portfolio in Q4 2022.
  • Candriam SCA opened 50 new positions and closed 57 in Q4 2022.
  • Candriam SCA's portfolio value rose 4.4% quarter-over-quarter to $14.8B.

Based on Candriam SCA's 13F filing for Q4 2022, filed 13 Feb 2023.